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Abstract
Objectives: To measure HIV prevalence and uptake of HIV counseling and testing (HCT) in a peri-urban South African
community. To assess predictors for previous HIV testing and the association between the yield of previously undiagnosed
HIV and time of last negative HIV test
Methods: A random sample of 10% of the adult population ($15 years) were invited to attend a mobile HCT service. Study
procedures included a questionnaire, HIV testing and CD4 counts. Predictors for previous testing were determined using a
binominal model.
Results: 1,144 (88.0%) of 1,300 randomly selected individuals participated in the study. 71.0% (68.3–73.6) had previously had
an HIV test and 37.5% (34.6–40.5) had tested in the past 12 months. Men, migrants and older (.35 years) and younger (,20
years) individuals were less likely to have had a previous HIV test. Overall HIV prevalence was 22.7 (20.3–25.3) with peak
prevalence of 41.8% (35.8–47.8) in women aged 25.1–35 years and 37.5% (26.7–48.3) in men aged 25.1–45 years. Prevalence
of previously undiagnosed HIV was 10.3% (8.5–12.1) overall and 4.5% (2.3–6.6), 8.0% (CI 3.9–12.0) and 20.0% (13.2–26.8) in
individuals who had their most recent HIV test within 1, 1–2 and more than 2 years prior to the survey.
Conclusion: The high burden of undiagnosed HIV in individuals who had recently tested underscores the importance of
frequent repeat testing at least annually. The high prevalence of previously undiagnosed HIV in individuals reporting a
negative test in the 12 months preceding the survey indicates a very high incidence. Innovative prevention strategies are
needed.
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Introduction
HIV counseling and testing (HCT) services are important entry
points for prevention and care [1]. Studies from different countries
have shown that individuals take precautions to protect their
partners once they know they are HIV positive [2,3,4] and
modeling studies have found HCT to offer substantial clinical
benefits and to be cost-effective even in settings where linkage and
access to care is limited [5].
The past decade has seen a rapid global scale-up of HCT [6].
Recent surveys from Tanzania, the Democratic Republic of the
Congo, Kenya, Zambia, Swaziland and South Africa reported that
between 8.6 and 56.6% of women and 9.2 and 43.0% of men ever
had an HIV test [6,7]. HCT uptake is associated with a range of
socio-demographic factors, and is generally lower among men,
younger and older age groups, those with limited education and
income [6,8,9]. Identifying characteristics of individuals who have
never tested is important to develop services targeted at first time
testers and thus to achieve universal access to HCT.
Sexually active individuals in high HIV prevalence settings are
at continuous risk of infection and should therefore test at regular
intervals. The World Health Organization (WHO) recommends
annual testing in high HIV prevalence settings as do the 2010
South African guidelines [10,11]. A recent study from South
Africa found annual screening to be very cost-effective even in the
Western Cape, the province with the lowest rates of HIV infection
in South Africa [5]. Despite the importance of annual testing,
population surveys from six sub-Saharan African countries showed
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in the 12 months preceding the survey [6]. Even though South
Africa is above average with 24.7% of the population reporting a
test within the last 12 months in 2008, it is still sub-optimal [7].
This study was conducted in a well characterized peri-urban
community in the Western Cape, South Africa [12,13]. The study
community has been exposed to 9 years of community-based HIV
prevention research and has seen provider-initiated HIV testing
and antiretroviral therapy (ART) roll-out earlier than most other
communities in South Africa. This community provides a unique
opportunity to examine the effect of high HCT coverage and
frequent testing. The aims of this study were to measure HIV
prevalence and HCT uptake, to determine predictors for previous
HIV testing and to assess the association between the yield of
previously undiagnosed HIV and time of last negative test.
Methods
Ethics statement
Written informed consent was obtained from all individuals
participating in the study. Data collection and analysis was
approved by the University of Cape Town Ethics Committee and
Partners Human Subjects Institutional Review Board and the
London School of Hygiene and Tropical Medicine.
Setting
The study was based in a peri-urban township in the greater
area of Cape Town, South Africa. Regular household censuses
have shown that the community has undergone a rapid population
growth from 5000 residents in 1996 to 17000 in the most recent
census in August 2010 [12]. Adult HIV prevalence was 23% in
2005 and 25% in 2008 as measured in previous population based
HIV prevalence surveys.
The community was served by a single public-sector primary
care clinic, which provided outpatient care including HCT and
ART free of charge. A nearby hospital (5 km away) provided all
secondary care, including inpatient and antenatal services. The
hospital also provided ART for some HIV-infected individuals
from the community. ART provision at the primary health care
clinic and hospital began in 2004. Since 2005, there has been a
significant scale-up of the ART program in this community, with
13% of all individuals infected with HIV receiving ART in 2005
and 21% in 2008 [14].
Voluntary counseling and testing services have been available to
all individuals accessing either the local clinic or the hospital since
2001 with provider-initiated testing routinely given to any patient
accessing TB services whose HIV status was unknown; this was
extended to all pregnant females accessing the hospital or clinic in
2002 and patients accessing STI services in 2007. HIV testing
rates rose from 4% of the total population per year in 2001 to 20%
in 2006 [15]. The total number of tests performed in the primary
health care clinic or hospital among residents of this community
was more than 10500 between January 2004 and March 2009
[16]. The community has also been served by a mobile HCT
service 1–2 days per month since July 2008. The mobile HCT
service has done more than 1000 tests in this community.
Community-based cross-sectional survey
A population-based HIV sero-prevalence survey was conducted
between September and December 2010. A house-to-house
enumeration of the community in August 2010 provided a
database of 12520 residents 15 years or older of whom 1300
residents were randomly selected for inclusion in the study (10% of
the community). Simple random sampling was performed using
Stata 11.0 (Stata Corp. LP, College Station, TX, United States of
America). Each adult resident in the community had an equal
chance of being selected for the survey. The census 2010 data were
used as a sampling frame. Field workers invited the selected
individuals to attend the mobile HIV testing service. Field workers
visited households of selected individuals up to 5 times to
encourage participation. No study procedures were performed in
people’s homes. Consent, questionnaires and HIV testing were
performed at the mobile HIV testing service when a potential
participant attended the service.
Mobile HIV testing service
The mobile HIV testing service used in this study has been
described elsewhere [17]. In brief, this nurse-run and counselor-
supported unit provides free HCT services in combination with
free screening for other chronic conditions (i.e. hypertension,
diabetes and obesity) and TB. HIV testing is performed according
to the Provincial Government of the Western Cape guidelines
[18]. Whilst the South African guidelines for HIV testing
recommend written informed consent, the mobile, community
based nature of this service led to the agreement by local health
authorities to allow verbal consent in clients voluntarily accessing
this service since 2008. Individuals approaching the mobile
services give verbal consent for HIV testing which is recorded
on the consultation form.
The mobile testing service was parked in front of the primary
school in the centre of the community. It operated on weekdays
and weekends as well as after hours to ensure that individuals with
regular work had an opportunity to participate.
Participants could choose one of three options to receive their
result: i) to test and receive their HIV result together with
screening for chronic diseases, ii) to provide blood and not receive
their HIV result, but undergo screening for chronic diseases or iii)
to only provide blood and not receive their HIV result. Individuals
who consented to rapid HIV testing and tested positive were
subsequently staged according to the WHO staging manual and
underwent a point of care CD4 count test (Alere
TMPima
TM CD4
Analyser, Waltham, MA, USA) using venous blood samples. All
participants were compensated for transport and time with ZAR
70 (approximately 9.6 US dollars) gift vouchers.
Data collection and management
Age, sex, nationality, migration history and previous HIV
testing experience were recorded via a short questionnaire. Data
were double entered and verified in EpiData version 3.1.
For HIV testing experience this included asking whether they
had tested for HIV before and whether this was ,3 months ago,
3–6 months ago, 6–12 months ago, 1–2 years ago or .2 years ago.
Where individuals had tested on the mobile clinic before, this
information was available from their previous records accessed
using a biometric system. Recent migrants were defined as
individuals who had moved into this community from either
within South Africa or from neighboring countries within the 3
years preceding the survey.
Individuals who tested HIV positive and chose to receive their
result were asked as part of the questionnaire if they were aware of
their positive sero-status. Individuals who were unaware of their
positive sero-status underwent the routine procedure of the mobile
testing service for newly diagnosed HIV positive individuals. These
procedures included clinical staging, CD4 count testing, pregnan-
cy tests for women, screening for sexually transmitted disease,
referrals to primary health care clinics and targeted counseling. All
newly diagnosed HIV positive individuals were called by their
counselor 7 days after diagnoses to ensure that they received
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extremely experienced and as such able to confirm if an individual
was unaware of their sero-status. Twelve individuals who initially
said that they were unaware of their HIV positive sero-status
admitted to the counselor that they had known their positive sero-
status before. This information was used to amend the data. For
patients who chose to test anonymously and tested positive
(N=16) no additional information could be collected by the
counselors.
Statistical analysis
All analyses were carried out using Stata version 11.0 (Stata
Corp. LP, College Station, TX, United States of America).
Proportions and confidence intervals were calculated for categor-
ical variables, and medians and interquartile ranges for continuous
variables. The proportion of individuals who tested for HIV within
the last year was calculated using individuals at risk for testing as a
denominator. Thus, the denominator excluded individuals who
had tested HIV positive more than one year ago. The prevalence
of newly diagnosed HIV in individuals who had tested before
excluded individuals known to be HIV positive from the
denominator.
Differences in proportions between study participants who had
tested previously and study participants who had never tested were
calculated using cross-tabulation and x2 test.. Risk ratios
investigating association between age, gender, nationality, migra-
tion and previous HIV testing were calculated using a binominal
model. Differences in median CD4 counts in individuals newly
diagnosed with HIV, known to be HIV positive but not on ART
and individuals on ART was assessed using the Kruskal-Wallis
test.
Results
Characteristics of the study population
Of 1300 individuals randomly selected from the community,
1144 (88.0%) participated. Among the 156 individuals who did
not participate in the study two had died before the study started,
five refused to participate, and the remaining 149 did not attend
the mobile HCT service despite multiple visits to their households.
Individuals who did not participate in the study were older
(median age 31; IQR [interquartile range] 27–38) and more likely
to be men (76.2%) compared to individuals who participated in
the study (median age 28; IQR 23–35, 48.6% men) (table 1).
The majority of study participants were South African and
approximately one quarter had migrated to the study community
within the last 3 years. Most migrants came from a neighboring
province, the Eastern Cape, (52.6%) while 11.9% came from
elsewhere in the Western Cape and 22.6% from neighboring
countries. Non-South Africans (77.1%) were more likely to have
recently migrated to the study community compared to South
Africans (32.3%).
Prevalence and predictors of previous HIV testing
71.0% (95% CI 68.3–73.6) of study participants had previously
had an HIV test and more than one third (37.5%) had tested in the
12 months preceding the survey (table 1). The proportions of
women, South Africans and long term residents were higher
among individuals who had previously tested for HIV than among
individuals who had never tested (table 2). In multivariate analysis
women and South African nationals were more likely to have a
previous HIV test. Migrants and younger and older individuals
were less likely to have been tested before.
HIV prevalence
Overall the proportion of people tested who agreed to receive
their result was high (94.2%, 95%CI 92.9–95.6). A total of 66
individuals chose to test anonymously among whom 16 (24.2%)
tested positive.
Overall HIV prevalence was 22.7% (95%CI 20.3–25.3). Just
over half (54.6%, 95%CI 48.3–60.8) of the HIV-infected
individuals knew their serostatus (table 1). Among the 142 HIV
infected individuals who knew their positive serostatus, 87 were on
ART (61.3%, 95%CI 52.7–69.3). The median CD4 count was 389
cells/uL (IQR 269–611) in individuals newly diagnosed with HIV,
430 cells/uL (IQR 287–631) in individuals known to be HIV
positive but not on ART and 440 cells/uL (IQR 295–627) in
individuals on ART. CD4 counts were not significantly different
across the three groups.
HIV prevalence and the proportion of undiagnosed HIV was
associated with age and sex (figure 1). HIV prevalence was 12.1%
(95%CI 7.4–16.8) in women 15–25 years of age compared to
41.8% (95%CI 35.8–47.8) in women aged 25.1–35. HIV
prevalence in men was highest among the 35.1–45 year olds
(37.5%, 95% 26.7–48.3). The proportion of positive tests that were
new HIV diagnoses was significantly higher in men (62.1%,
95%CI 51.0–72.3) compared to women (37.0%; 95%CI 29.8–
44.7).
Prevalence of previously undiagnosed HIV
Prevalence of previously undiagnosed HIV was 18.4% (95%CI
14.2–22.4) in individuals who had never tested for HIV and 8.5%
(95%CI 6.4–10.6) in individuals who reported HIV testing prior to
the survey (p,0.001). Prevalence of previously undiagnosed HIV
was 4.5% (95%CI 2.3–6.6), 8.0% (95%CI 3.9–12.0) and 20.0%
(95%CI 13.2–26.8) in individuals who had their most recent HIV
test within 1 year, 1–2 years and more than 2 years prior to the
survey. There was no difference in prevalence in individuals last
tested ,3 (4.1%), 3–6 (4.9%), 6–12 (4.9%) months prior to the
survey. A sensitivity analysis excluding the 16 individuals who
tested positive but did not want to receive their test results revealed
Table 1. Characteristics, HCT coverage and HIV prevalence
(N=1144).
Variables N Percent 95% CI
Characteristics of participants
Testing and receiving result 1078 94.2 92.9; 95.6
Women 588 51.4 48.5; 54.3
Age ,20 years 134 11.7 9.9; 13.7
Age 20–34.9 years 714 62.4 59.5; 65.2
Age $35 years 296 25.9 23.4; 28.5
South African 1034 90.4 88.7; 92.1
Moved into the community
during the past 3 years
309 27.2 24.6; 29.8
Previous HIV testing
Previously tested for HIV 812 71.0 68.3; 73.6
Tested within the last year 386 37.5 34.6; 40.5
HIV prevalence
Newly diagnosed HIV+ 118 10.3 8.6; 12.1
Known HIV+ 142 12.4 10.5; 14.3
HIV- 884 77.3 74.8; 79.7
doi:10.1371/journal.pone.0025244.t001
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individuals last tested ,3 months ago (1.2%).
In long-term residents, prevalence of previously undiagnosed
HIV was 3.9% among those tested within 12 months and 6%
among those tested within 1–2 years prior to the survey .
Individuals who had recently moved into the community had a
higher prevalence of previously undiagnosed HIV: 6.1% in
individuals tested in the past 12 month and 14.3% in individuals
tested 1–2 years ago.
Discussion
This cross-sectional population based sero-survey found a peak
HIV prevalence in the age group 25.1–35 in women (41.8%) and
35.1–45 in men (37.5%) in this peri-urban community. Almost
half (45.4%) of the individuals infected with HIV were unaware of
their HIV positive sero-status despite 71.0% of the population
reporting that they had previously had an HIV test. Younger and
older individuals, immigrants, individuals who had recently moved
to the community and men were less likely to have previously
tested for HIV. The prevalence of undiagnosed HIV was strongly
associated with a history of HIV testing. Even among individuals
who reported their most recent negative HIV test in the 12 months
prior to the survey, the prevalence was 4.5%. CD4 count
distributions were similar in HIV positive individuals on ART
and not ART probably due to high ART coverage in this
community [19].
In this community 71.0% had previously tested for HIV and
37.5% had an HIV test within the last 12 months. This is
substantially higher than the corresponding national estimates
Table 2. Comparison of previously tested and untested individuals (N=1144).
Variables
Previously tested
for HIV (N=812)
Never tested
for HIV (N=332)
p value
(x
2 test)
Predictors of
previous HIV test
N Percent 95% CI N Percent 95% CI RR 95% CI p value
Women 486 59.9 56.5; 63.2 102 30.7 25.7; 35.7 ,0.01 1.33 1.33; .143 ,0.01
Age ,20 years 75 9.2 7.3; 11.4 59 17.8 13.8; 22.2 ,0.01 0.79 0.68; 0.91 ,0.01
Age 20–34.9 years 532 65.5 62.1; 68.8 182 54.8 49.3; 60.3 1.00
Age $35 years 205 24.3 22.3; 28.4 91 27.4 22.7; 32.5 0.87 0.81; 0.95 ,0.01
South African 758 93.3 91.6; 95.1 276 83.1 79.1; 87.2 ,0.01 1.29 1.06; 1.57 0.01
Moved into the community
during the past 3 years
187 23.1 20.2; 26,1 122 37.2 31.9; 42.5 ,0.01 0.83 0.80; 0.95 0.02
doi:10.1371/journal.pone.0025244.t002
Figure 1. HIV prevalence by age and sex.
doi:10.1371/journal.pone.0025244.g001
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were strengthened and provider-initiated as well as voluntary
testing was implemented as early as 2002 through the ongoing
research program in this community which might explain some of
the differences. Furthermore HCT has been scaled up on a
national and provincial level over the last years. [7]. In April 2010
a national HCT campaign was launched aiming to test 15 million
people for HIV by June 2011. This might have led to increased
testing rates in the months before this survey.
In a community with such high testing rates one would expect
the majority of HIV infected individuals to be aware of their HIV
positive sero-status. The high proportion (45.6%) of undiagnosed
HIV in this community may be due to a very high incidence.
This study was not designed to measure HIV incidence. However
a 4.5% prevalence of undiagnosed HIV in individuals reporting a
negative test within the last 12 months translates into an
incidence of 12.4 per 100 person-years assuming that the
infection occurred at the mid-point between the last negative
test and the positive test. Even when excluding individuals who
tested positive, but did not want to receive their results, as these
individuals might have known their positive sero-status before,
the HIV incidence remains at 8.5 per 100 person-years. The
method used to calculate these incidence estimates has not been
validated and thus the estimates should be viewed with caution.
They are, however in keeping with the incidence of 7.2 per 100
person-years reported from a cohort in this community in 2004–
2005 [20]. Similar incidence rates of 6.4 per 100 person-years
have been reported in women in rural and urban in KwaZulu
Natal, South Africa [21]. These incident rates are in stark
contrast to a recent estimate of 1.3 per 100 person-years using
data from three national surveys [22]. National incidence
estimates provide an average of incidence estimates across South
Africa therefore very high incidence in some communities [23]
might be compensated for by low incidence in others. In addition,
it is well recognized that the South African HIV epidemic is
heterogeneous with wide inter- and intra- provincial variation in
HIV prevalence and incidence rates.
Individuals tested more recently are a self-selected group who
might be at higher risk of HIV infection, which might bias the
HIV incidence estimate. With almost a third of the population
reporting that they had moved to the community in the last 3 years
incidence might be overestimated due to high risk of HIV infection
in migrants [24,25]. Restricting the analysis to long-term residents
only, reveals an HIV incidence estimate of 6.1/100 person-years,
which is still extremely high. The HIV prevalence of 12.1%
among young women provides further evidence for a very high
HIV incidence in this community.
The high incidence in this community and the high prevalence
of HIV in women aged 25.1–45 show that current prevention
efforts – even in a setting where HIV prevention research is
conducted – are failing. HIV prevalence estimates from this
community with a peak prevalence of 41.8% in women and 37.5%
in men are as high as reported from rural Kwazulu Natal, the
South African province hardest hit by the HIV epidemic [26].
This community was exposed to more intensive prevention
messages and better resourced HIV services than most other
South African communities as evidenced by higher HCT coverage
and the lower prevalence of newly diagnosed HIV in repeat testers
in long-term residents as compared to recent migrants.
However prevention tools in 2011 are still very limited and these
data would indicate that testing and awareness alone are
insufficient to reduce HIV acquisition risk. Of note, a high HIV
incidence has also been reported from the CAPRISA 004
microbicide trial in KwaZulu Natal, South Africa. Women
participating in the CAPRISA 004 trial were all exposed to a
package of prevention consisting of condoms, monthly testing and
risk reduction counseling, but even so HIV incidence was reported
at 9 per 100 person-years in the placebo assigned study group [27].
Clearly there is a need for additional and innovative prevention
programs to reduce HIV incidence.
The high prevalence of undiagnosed HIV even in individuals
who reported testing negative within the 3 months preceding the
survey underscores the importance of counseling individuals on
the window period as well as frequent repeated HIV testing
especially for those at high risk of HIV infection. However,
another reason for the high prevalence of undiagnosed HIV
despite recent testing might be the low sensitivity of rapid HIV
tests due to poor adherence with correct testing procedures in
routine clinical practice and previous testing in the ‘window
period’ during serocoversion [28].
Any annual screening program for a chronic and possibly fatal
disease using a cheap point of care rapid test with a yield of 4.5%
should be cost-effective [5]. With a yield of 4.5% in individuals
who had tested negative in the 6 months preceding the survey even
more frequent testing might be justified.
Previous testing experience and awareness of the HIV positive
sero-status was assessed by self report which might be influenced
by social desirability bias. In addition the exact time of testing
might have been influenced by recall bias resulting in misclassi-
fication. Some of the individuals participating in the survey had
tested at the mobile clinic before (N=50). All but two reported the
correct time of previous test. Bias and chance could explain the
steady prevalence of 4–5% in individuals tested within 0–3
months, 3–6 months and 6–12 months prior to the survey.
However an alternative explanation is that individuals testing at
higher frequency might have a higher risk of HIV infection or that
anonymous testers who tested positive in this survey knew their
status already. Excluding those individuals did not change the
overall results.
This study found that men, non-South Africans, younger and
older individuals and individuals who had moved to the
community within the last 3 years were less likely to have ever
tested before, consistent with other studies from South Africa
[7,25,29,30]. More importantly the yield of newly diagnosed HIV
was twice as high in individuals who had never tested before
compared to individuals who reported a prior HIV test,
emphasizing the need for frequent testing and expanding services
to segments of the population which are hard to reach. This study
highlights again that men are particularly underserviced as almost
two thirds of HIV infected men were unaware of their HIV
positive sero-status.
Among the limitations of this study are: a non-attendance rate
of 12%. Reasons for non-attendance were temporary absentee-
ism (prolonged visits to the neighboring province), work
commitment and silent refusals. These data are similar to other
population based HIV sero-prevalence surveys from sub-
Saharan Africa reporting absenteeism rates of 0.8–35.2% and
refusal rates of 2.7–35.9% [31,32,33]. HIV prevalence found in
this survey is consistent with estimates from previous surveys
from the same community [34], thus non-response bias due to
differences in age and gender between attendees and non-
attendees seems negligible.
Fear of stigma and lack of confidentiality have been shown to be
a major barrier for HIV testing [35,36,37,38,39,40]. The high
uptake of open (non-anonymous testing) is particularly encourag-
ing and might be attributed to a well functioning and efficient
ART program, reduced stigma due to a long period (9 years) of
community-based HIV prevention research in this community
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HCT service were part of the community.
In conclusion this study showed a high burden of undiagnosed
HIV despite high HCT coverage. The yield of previously
undiagnosed HIV was 4.5% in individuals with a negative HIV
test within 12 months preceding the survey. This suggests a very
high HIV incidence. The results emphasize the importance of
repeat testing perhaps even more frequently than annually. It
underscores the notion that innovative and effective prevention
interventions in addition to post test counseling are urgently
required.
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